GHK Restores TGF-Beta Pathway in COPD Lungs A collaborative study conducted by scientists from Boston University, University of Groningen, University of British Columbia, and University of Pennsylvania established that the GHK peptide reverses the gene expression signature of COPD, which is manifested by emphysema, inflammation, lung tissue destruction, and significant reduction of lung capacity
thus, the depletion of Fusobacteria correlated with the relapse risk of pediatric MS
Beat-up DNA accelerates your risk of diseases like Parkinsons disease, atherosclerosis, heart attack, and cancer, and can speed up your aging process (11)
The rationale for testing drug combinations in aging intervention studies
can be extremely costly
Oral glutathione shows 1820% bioavailability